BEIJING: Four kinds of vaccine for the H7N9 strain of bird flu virus have been approved for clinical trials by China’s top drug regulator, according to the Beijing Food and Drug Administration.
The administration will continue to provide assistance and guidance for clinical trials of the vaccines so they can enter the market as soon as possible, it said in a statement last week.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!